Andropause: Understanding Male Menopause & Testosterone Decline

Men with total testosterone below 300 ng/dL have 2.4x higher cardiovascular mortality compared to those above 600 ng/dL (Journal of Clinical Endocrinology & Metabolism, 2018). While the term “male menopause” is frequently used, the more clinically accurate term is “andropause” or “late-onset hypogonadism.” Unlike the abrupt hormonal shift women experience during menopause, men undergo a gradual decline in testosterone production that typically begins in their late 20s or early 30s. This decline averages about 1% per year, but the rate and symptomatic impact vary significantly between individuals. Understanding these age-related hormonal changes is crucial for informed health management and improving quality of life as men age.

Last Updated: OCTOBER 2023

Understanding Andropause: A Gradual Shift

Andropause describes the constellation of symptoms and physiological changes associated with age-related decline in testosterone. It is not a sudden event but a progressive process. The testes continue to produce testosterone throughout a man’s life, but their efficiency diminishes. This reduction in androgen levels can significantly impact various bodily functions, affecting energy, mood, sexual function, body composition, and overall well-being.

The endocrine system, responsible for hormone production, undergoes several changes with aging. The Leydig cells in the testes, which produce testosterone, may become less responsive to luteinizing hormone (LH) signaling from the pituitary gland. Concurrently, the pituitary’s sensitivity to gonadotropin-releasing hormone (GnRH) from the hypothalamus can also change. Another key factor is an age-related increase in Sex Hormone Binding Globulin (SHBG). SHBG binds to testosterone, making it unavailable for tissue use. Higher SHBG means less free, bioavailable testosterone, even if total testosterone levels appear adequate.

Symptoms of Declining Testosterone

The symptoms of andropause can be subtle and overlap with other common age-related conditions, making diagnosis challenging. Many men attribute these symptoms to “just getting older” without realizing the hormonal component. Recognizing these signs is the first step toward addressing potential imbalances.

Common symptoms include:

• Reduced libido and sexual function: Decreased sex drive, erectile dysfunction, fewer spontaneous erections.
• Fatigue and decreased energy levels: Persistent tiredness, lack of motivation.
• Mood disturbances: Increased irritability, anxiety, depression, difficulty concentrating.
• Changes in body composition: Increased abdominal fat, decreased muscle mass and strength.
• Decreased bone density: Increased risk of osteoporosis and fractures.
• Sleep disturbances: Insomnia or altered sleep patterns.
• Hot flashes and sweats: Though less common than in women, they can occur in severe cases of hypogonadism.
• Reduced hair growth: Thinning body hair.

These symptoms often appear gradually, making it difficult to pinpoint their onset. A comprehensive evaluation, including symptom assessment and blood work, is essential for an accurate diagnosis.

Diagnosing Low Testosterone: Beyond the Numbers

Accurate diagnosis of low testosterone relies on a combination of clinical symptoms and laboratory testing. Blood tests typically measure total testosterone, free testosterone, and SHBG. Other important markers include luteinizing hormone (LH), follicle-stimulating hormone (FSH), estradiol (E2), complete blood count (CBC), PSA, and lipid profile.

The Problem with “Normal” Ranges

One of the most significant barriers to proper diagnosis and treatment is the conventional reference range for total testosterone. The commonly cited lower limit of 264–300 ng/dL for total testosterone was established decades ago, often derived from populations that included older, less healthy individuals. These ranges do not account for optimal physiological function or individual variability.

As stated by Dr. Abraham Morgentaler, “The use of an arbitrary threshold for total testosterone, often below 300 ng/dL, as the sole criterion for diagnosing hypogonadism is inadequate and can lead to undertreatment of symptomatic men” (Morgentaler, 2017, Testosterone for Life). This highlights the anti-gatekeeping stance: simply falling above an outdated threshold does not negate the presence of debilitating symptoms. Optimal ranges often fall significantly higher, with many symptomatic men feeling their best when total testosterone levels are in the 600–900 ng/dL range, and free testosterone between 15–25 pg/mL.

Essential Lab Values for Diagnosis and Monitoring

Navigating Treatment Options: Precision and Autonomy

Once low testosterone is diagnosed and contributing factors are identified, several treatment options are available. The goal of Testosterone Replacement Therapy (TRT) is to restore physiological testosterone levels, alleviate symptoms, and improve overall health markers. Each approach has its nuances, and the choice often depends on individual goals, such as fertility preservation or specific symptom relief.

Testosterone Injections: Cypionate and Enanthate

Injectable testosterone esters like testosterone cypionate and testosterone enanthate are the most common and effective forms of TRT. They are administered intramuscularly or subcutaneously.

• Typical dosing: 100–200mg testosterone cypionate or enanthate per week, split into 1–2 injections. For example, 50–100mg twice weekly. This protocol helps maintain more stable blood levels and minimizes estrogenic side effects compared to a single large weekly dose.
• Advantages: Cost-effective, highly effective in raising T levels, greater control over dosage.
• Disadvantages: Requires injections, can impact endogenous testosterone production and fertility.

Human Chorionic Gonadotropin (HCG)

HCG mimics LH, stimulating the testes to produce their own testosterone and maintain testicular size. It is often used in conjunction with testosterone injections to preserve fertility and prevent testicular atrophy.

• Typical dosing: 500–1000 IU HCG two to three times per week.
• Advantages: Preserves testicular function and fertility, maintains natural hormone production pathways.
• Disadvantages: Additional injections, can increase estradiol levels, requiring careful monitoring.

Enclomiphene Citrate: A Fertility-Sparing Option

Enclomiphene is a selective estrogen receptor modulator (SERM) that blocks estrogen’s negative feedback on the hypothalamus and pituitary. This leads to increased production of LH and FSH, stimulating the testes to produce more testosterone endogenously.

• Typical dosing: 12.5–25mg enclomiphene daily.
• Advantages: Stimulates natural testosterone production, preserves fertility, avoids exogenous testosterone administration.
• Disadvantages: May not be potent enough for severe hypogonadism, requires functioning testicular tissue.

Anastrozole: Estrogen Management (Use with Caution)

Anastrozole is an aromatase inhibitor (AI) that blocks the conversion of testosterone to estradiol. While often prescribed to manage elevated E2 levels on TRT, its use requires extreme caution. Over-suppressing E2 can lead to joint pain, mood disturbances, decreased libido, and negative impacts on bone density and cardiovascular health.

• Typical dosing: 0.25–0.5mg anastrozole once or twice per week, only if E2 levels are consistently above 40 pg/mL AND symptomatic. Many men feel optimal with E2 in the 20–40 pg/mL range without an AI.
• Advantages: Can mitigate estrogenic side effects like gynecomastia and water retention.
• Disadvantages: Risk of over-suppression, potential negative health consequences from low E2. AIs should be used sparingly and judiciously.

Monitoring and Optimization: A Continuous Process

TRT is not a “set it and forget it” treatment. Regular monitoring is essential to ensure efficacy, manage side effects, and optimize hormone levels for individual well-being. This involves periodic blood work